✦ LIBER ✦

TCT-280: Percutaneous Coronary Intervention with Drug Eluting Stent in Patients with Stable Coronary Artery Disease: Late Clinical Follow-Up to 8 Years in aLarge Cohort of Patients from the Real-World-Real

Book ID: 119269756
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 150 KB
Volume: 56
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2010.08.304

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TCT-415: Comparison On The Incidence Of

TCT-415: Comparison On The Incidence Of Late Thrombosis After Implantation Of Different Drug-eluting Stents In Patients With Real World Coronary Artery Disease -three-year Follow-up Results

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 200 KB

Improved Late Clinical Safety With Zotar

Improved Late Clinical Safety With Zotarolimus-Eluting Stents Compared With Paclitaxel-Eluting Stents in Patients With De Novo Coronary Lesions: 3-Year Follow-Up From the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) Trial

✍ Martin B. Leon; Eugenia Nikolsky; Donald E. Cutlip; Laura Mauri; Henry Liberman; 📂 Article 📅 2010 🏛 American College of Cardiology 🌐 English ⚖ 557 KB

Clinical usefulness of the Driver®stent

Clinical usefulness of the Driver®stent in a retrospective, collaborative, multicenter, open-label study in Japanese real-world patients with coronary artery disease and the drug-eluting stent era

✍ Shinsuke Nanto; Masaki Awata; Hideki Shimomura; Takatoshi Hayashi; Shinjo Sonoda 📂 Article 📅 2011 🏛 Springer Japan 🌐 English ⚖ 177 KB

Long-term clinical benefit of drug-eluti

Long-term clinical benefit of drug-eluting stents over bare-metal stents in diabetic patients with de novo left main coronary artery disease: Results from a real-world multicenter registry

✍ Davide Capodanno; Maria Elena Di Salvo; Tullio Palmerini; Imad Sheiban; Massimo 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 321 KB 👁 3 views

TCT-410: I-LOVE-IT - A Prospective, Mult

TCT-410: I-LOVE-IT - A Prospective, Multicenter Clinical Trial of TIVOLI Bioabsorbable Polymer Based Sirolimus-Eluting vs. ENDEAVOR Zotarolimus-Eluting Stent in Patients with Coronary Artery Disease: 8-Month Angiographic and 1-Year Clinical Follow-Up Results

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 185 KB